Investors are getting younger and more vocal
Global equity struggles
Company trading on a 28.4% premium
ii says “time to evolve”
Unilever has faced a tumultuous few weeks as news of its failed £50bn bid to buy GlaxoSmithKline’s consumer health unit came to light along with job cuts, scathing remarks from star fund managers and an activist investor taking a position.
Q4 Boring Money Fund Investor Tracker
Responses due 23 March